Role of Intestinal Bacteria in Gliadin-Induced Changes in Intestinal Mucosa: Study in Germ-Free Rats
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND AIMS: Celiac disease (CD) is a chronic inflammatory disorder of the small intestine that is induced by dietary wheat gluten proteins (gliadins) in genetically predisposed individuals. The overgrowth of potentially pathogenic bacteria and infections has been suggested to contribute to CD pathogenesis. We aimed to study the effects of gliadin and various intestinal bacterial strains on mucosal barrier integrity, gliadin translocation, and cytokine production. METHODOLOGY/PRINCIPAL FINDINGS: Changes in gut mucosa were assessed in the intestinal loops of inbred Wistar-AVN rats that were reared under germ-free conditions in the presence of various intestinal bacteria (enterobacteria and bifidobacteria isolated from CD patients and healthy children, respectively) and CD-triggering agents (gliadin and IFN-γ) by histology, scanning electron microscopy, immunofluorescence, and a rat cytokine antibody array. Adhesion of the bacterial strains to the IEC-6 rat cell line was evaluated in vitro. Gliadin fragments alone or together with the proinflammatory cytokine interferon (IFN)-γ significantly decreased the number of goblet cells in the small intestine; this effect was more pronounced in the presence of Escherichia coli CBL2 and Shigella CBD8. Shigella CBD8 and IFN-γ induced the highest mucin secretion and greatest impairment in tight junctions and, consequently, translocation of gliadin fragments into the lamina propria. Shigella CBD8 and E. coli CBL2 strongly adhered to IEC-6 epithelial cells. The number of goblet cells in small intestine increased by the simultaneous incubation of Bifidobacterium bifidum IATA-ES2 with gliadin, IFN-γ and enterobacteria. B. bifidum IATA-ES2 also enhanced the production of chemotactic factors and inhibitors of metalloproteinases, which can contribute to gut mucosal protection. CONCLUSIONS: Our results suggest that the composition of the intestinal microbiota affects the permeability of the intestinal mucosa and, consequently, could be involved in the early stages of CD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbial modulation of innate defense: goblet cells and the intestinal mucus layer
Deplancke, B., & Gaskins, H. R. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1131s · Cited by 1,012
IgA Response to Symbiotic Bacteria as a Mediator of Gut Homeostasis
Peterson, D. A., McNulty, N. P., Guruge, J. L., & Gordon, J. I. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.013 · Cited by 828
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001308 · Cited by 482 · cited 1×
“others [48–50], could be a consequence of partial aggregation,”
BackgroundMucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon
Barcelo, A., Claustre, J., Moro, F., Chayvialle, J.-A., Cuber, J.-C., & Plaisancié, P. (2000) · Gut · doi:10.1136/gut.46.2.218 · Cited by 375 · cited 1×
“Studies have shown that dietary factors affect goblet cell numbers and modulate their secretory activity [37,42,43].”
BackgroundSpecific duodenal and faecal bacterial groups associated with paediatric coeliac disease
Collado, M. C., Donat, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.061366 · Cited by 354 · cited 2×
“coli with virulence genes and by a reduction in Bifidobacterium proportions [6–10,24–26].”
BackgroundSelf-citationCollado, M. C., Donat, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-232 · Cited by 220
Self-citationDe Palma, G., Cinova, J., Stepankova, R., Tuckova, L., & Sanz, Y. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0709471 · Cited by 90 · cited 1×
“strains did not exert similar effects, confirming that the intestinal epithelial cells provided a physical barrier, preventing overstimulation and inhibiting monocyte activation”
BackgroundSelf-citation
Cited by
Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease
Pickard, J. M., Zeng, M. Y., Caruso, R., & Núñez, G. (2017) · Immunological Reviews · doi:10.1111/imr.12567 · Cited by 1,699
“expression of tight junction proteins (162).”
Mechanisms of inflammation-driven bacterial dysbiosis in the gut
Zeng, M. Y., Inohara, N., & Nuñez, G. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.75 · Cited by 877
Gut microbiome, obesity, and metabolic dysfunction
Tilg, H., & Kaser, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58109 · Cited by 860
“, Escherichia coli), and lead to impairment of tight junctions (57).”
BackgroundYu, L. C.-H. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0483-8 · Cited by 399
The interaction among gut microbes, the intestinal barrier and short chain fatty acids
Ma, J., Piao, X., Mahfuz, S., Long, S., & Wang, J. (2022) · Animal Nutrition · doi:10.1016/j.aninu.2021.09.012 · Cited by 398
Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications
Le Bastard, Q., Al‐Ghalith, G. A., Grégoire, M., Chapelet, G., Javaudin, F., Dailly, E., Batard, E., Knights, D., & Montassier, E. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14451 · Cited by 263
“75 Lipopolysaccharides from Enterobacteriaceae have been shown to exacerbate NSAID-induced intestinal injury and increase intestinal permeability.(76,77) Moreover, Enterobacteriaceae blooms are common in diseases involving inflammation, such as inflammatory bowel diseases, obesity, colorectal cancer and coeliac diseas…”
Wacklin, P., Kaukinen, K., Tuovinen, E., Collin, P., Lindfors, K., Partanen, J., Mäki, M., & Mättö, J. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828029a9 · Cited by 207
Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?
Cenit, M., Olivares, M., Codoñer-Franch, P., & Sanz, Y. (2015) · Nutrients · doi:10.3390/nu7085314 · Cited by 176
“of metalloproteinase inhibitors, and reduced gliadin translocation to the lamina propria, which could contribute to gut mucosal protection [112].”
BackgroundInfluentialSelf-citationDuodenal-Mucosal Bacteria Associated with Celiac Disease in Children
Sánchez, E., Donat, E., Ribes-Koninckx, C., Fernández-Murga, M. L., & Sanz, Y. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.00869-13 · Cited by 171
Self-citationKozakova, H., Schwarzer, M., Tuckova, L., Srutkova, D., Czarnowska, E., Rosiak, I., Hudcovic, T., Schabussova, I., Hermanova, P., Zakostelska, Z., et al. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.09 · Cited by 159
Self-citationModulation of post-antibiotic bacterial community reassembly and host response by Candida albicans
Erb Downward, J. R., Falkowski, N. R., Mason, K. L., Muraglia, R., & Huffnagle, G. B. (2013) · Scientific Reports · doi:10.1038/srep02191 · Cited by 136
Immune Development and Intestinal Microbiota in Celiac Disease
Pozo-Rubio, T., Olivares, M., Nova, E., De Palma, G., Mujico, J. R., Ferrer, M. D., Marcos, A., & Sanz, Y. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/654143 · Cited by 82
“In intestinal loops, B. bifidum CECT 7365 increased the number of goblet cells in the small intestine, which were reduced by the presence of gliadin, IFN-γ and enterobacteria, and upregulated ZO-1 expression, which was downregulated by CD triggers (gliadin peptides and IFN-γ) [106].”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Cinova, J., De Palma, G., Stepankova, R., Kofronova, O., Kverka, M., Sanz, Y., & Tuckova, L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-01-13
- Volume
- 6
- Issue
- 1
- Pages
- e16169
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2015111017
- Cited by
- 134
- References
- 7
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.